Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXHB2300028	HL231吸入溶液	HL-231	Inhalation	Chemical Drugs(2.2)	Supplementary Application	2023-01-31	Luoxin Aurovitas Pharma(Chengdu) Co Ltd;Sichuan Haisco Pharmaceutical Co Ltd	view
CXHB2300029	HL231吸入溶液	HL-231	Inhalation	Chemical Drugs(2.2)	Supplementary Application	2023-01-31	Luoxin Aurovitas Pharma(Chengdu) Co Ltd;Sichuan Haisco Pharmaceutical Co Ltd	view
CXHL2101379	HL231吸入溶液	HL-231	Inhalation	Chemical Drugs(2.2)	New Drug Application	2021-08-09	Sichuan Haisco Pharmaceutical Co Ltd	view
CXHL2101378	HL231吸入溶液	HL-231	Inhalation	Chemical Drugs(2.2)	New Drug Application	2021-08-09	Sichuan Haisco Pharmaceutical Co Ltd	view